Quarterly report [Sections 13 or 15(d)]

Condensed Statements of Stockholders' Equity (Deficit)

v3.25.1
Condensed Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Shares
Class A Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2023   $ 3 $ 3,419 $ 297,864 $ (314,333) $ (13,047)
Balances (in Shares) at Dec. 31, 2023 700,000 27,042,035        
Issuance of common shares, net of offering costs - Registered direct offering   $ 1   12,636   12,637
Issuance of common shares, net of offering costs - Registered direct offering (in shares)   1,275,000        
Issuance of common shares - Founders Agreement       396   396
Issuance of common shares - Founders Agreement (in shares)   193,905        
Stock-based compensation expense       709   709
Stock-based compensation expense (in shares)   2,680,106        
Exercise of pre-funded and common stock warrants (in shares)   3,795,233        
Net loss         (10,945) (10,945)
Balances at Mar. 31, 2024   $ 4 3,419 311,605 (325,278) (10,250)
Balances (in shares) at Mar. 31, 2024 700,000 34,986,279        
Balances at Dec. 31, 2024   $ 5 7,638 350,305 (370,573) (12,625)
Balances (in Shares) at Dec. 31, 2024 700,000 53,640,422        
Issuance of common shares - Founders Agreement     $ (7,638) 7,690   52
Issuance of common shares - Founders Agreement (in shares)   2,405,308        
Stock-based compensation expense       1,956   1,956
Stock-based compensation expense (in shares)   3,150,000        
Exercise of common stock warrants   $ 3   38,121   38,124
Exercise of common stock warrants (in shares)   23,868,003        
Net loss         (11,212) (11,212)
Balances at Mar. 31, 2025   $ 8   $ 398,072 $ (381,785) $ 16,295
Balances (in shares) at Mar. 31, 2025 700,000 83,063,733